Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CRI declined for three days, in of 296 cases, the price declined further within the following month. The odds of a continued downward trend are .
CRI moved below its 50-day moving average on August 15, 2023 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CRI crossed bearishly below the 50-day moving average on August 22, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Aroon Indicator for CRI entered a downward trend on September 20, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CRI's RSI Indicator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where CRI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on September 19, 2023. You may want to consider a long position or call options on CRI as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CRI just turned positive on September 14, 2023. Looking at past instances where CRI's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRI advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .
CRI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.269) is normal, around the industry mean (3.655). P/E Ratio (12.755) is within average values for comparable stocks, (96.421). CRI's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.358). Dividend Yield (0.044) settles around the average of (0.034) among similar stocks. P/S Ratio (0.840) is also within normal values, averaging (1.931).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of apparel and related products for babies and young children
|MFs / NAME||Price $||Chg $||Chg %|
|Allspring Util and Telecomms C|
|Hartford Capital Appreciation HLS IA|
|Fidelity Advisor® Materials Z|
|American Funds Growth Fund of Amer 529E|
|Nicholas Partners Small Cap Gr Instl|
A.I.dvisor indicates that over the last year, CRI has been loosely correlated with AEO. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRI jumps, then AEO could also see price increases.